Published in Eur J Haematol on March 01, 2008
Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study. J Clin Oncol (2009) 2.78
FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013? Hematology Am Soc Hematol Educ Program (2013) 1.31
Allogeneic stem cell transplantation in acute myeloid leukemia: establishment of indications on the basis of individual risk stratification. Dtsch Arztebl Int (2008) 1.02
Acute myeloid leukemia and myelodysplastic syndromes in older adults. J Clin Oncol (2014) 0.97
Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report. J Clin Oncol (2015) 0.92
Myelodysplastic Syndromes and Acute Myeloid Leukemia in the Elderly. Clin Geriatr Med (2016) 0.86
Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemia. J Mol Diagn (2009) 0.85
Profile of sapacitabine: potential for the treatment of newly diagnosed acute myeloid leukemia in elderly patients. Clin Interv Aging (2014) 0.78
Acute Myeloid Leukemia in the Elderly Patient: New Strategies. Rare Cancers Ther (2015) 0.75
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet (2009) 7.48
Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. J Clin Oncol (2008) 3.64
Microdissection based high resolution multicolor banding for all 24 human chromosomes. Int J Mol Med (2002) 2.74
Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia. J Clin Oncol (2009) 2.68
Increase in number of circulating disseminated epithelial cells after surgery for non-small cell lung cancer monitored by MAINTRAC(R) is a predictor for relapse: A preliminary report. World J Surg Oncol (2005) 1.97
Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma. BMC Cancer (2011) 1.74
Small supernumerary marker chromosomes (SMCs): genotype-phenotype correlation and classification. Hum Genet (2003) 1.57
Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort. Mod Pathol (2010) 1.55
Standardized quantification of circulating peripheral tumor cells from lung and breast cancer. Clin Chem Lab Med (2005) 1.40
SOX2 amplification is a common event in squamous cell carcinomas of different organ sites. Hum Pathol (2011) 1.40
Age, severe comorbidity and functional impairment independently contribute to poor survival in cancer patients. J Cancer Res Clin Oncol (2007) 1.33
Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring. Breast Cancer Res (2005) 1.22
Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells. Int J Oncol (2005) 1.21
Homologous sequences at human chromosome 9 bands p12 and q13-21.1 are involved in different patterns of pericentric rearrangements. Eur J Hum Genet (2002) 1.19
Tolerance to chemotherapy in elderly patients with cancer. Cancer Control (2007) 1.17
Impairment in functional status and survival in patients with acute myeloid leukaemia. J Cancer Res Clin Oncol (2006) 1.16
Rationale for treatment of metastatic squamous cell carcinoma of the lung using fibroblast growth factor receptor inhibitors. Chest (2012) 1.15
Detailed Hylobates lar karyotype defined by 25-color FISH and multicolor banding. Int J Mol Med (2003) 1.12
Quality-of-life in elderly patients with cancer: a short review. Eur J Cancer (2007) 1.11
Parental origin and timing of de novo Robertsonian translocation formation. Am J Hum Genet (2002) 1.06
Novel cryptic chromosomal rearrangements detected in acute lymphoblastic leukemia detected by application of new multicolor fluorescent in situ hybridization approaches. Int J Oncol (2006) 0.99
Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide. J Neurooncol (2009) 0.96
Co-morbidity and functional deficits independently contribute to quality of life before chemotherapy in elderly cancer patients. Support Care Cancer (2007) 0.96
Comorbidity in patients with cancer: prevalence and severity measured by cumulative illness rating scale. Crit Rev Oncol Hematol (2007) 0.95
Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial. Br J Haematol (2012) 0.95
Differential expression and regulation of bone morphogenetic protein 7 in breast cancer. Int J Oncol (2003) 0.95
SOX2 expression and prognostic significance in ovarian carcinoma. Int J Gynecol Pathol (2013) 0.93
Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch. Transfusion (2005) 0.93
Lack of regeneration of myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans with large anterior myocardial infarctions. Int J Cardiol (2004) 0.93
Clinical implications of molecular genetic aberrations in acute myeloid leukemia. J Cancer Res Clin Oncol (2009) 0.91
How many and which items of activities of daily living (ADL) and instrumental activities of daily living (IADL) are necessary for screening. Crit Rev Oncol Hematol (2006) 0.91
Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinoma. Lung Cancer (2011) 0.89
FISH banding methods: applications in research and diagnostics. Expert Rev Mol Diagn (2002) 0.88
Secondary resistance to sorafenib in two patients with acute myeloid leukemia (AML) harboring FLT3-ITD mutations. Ann Hematol (2010) 0.88
Preferred co-localization of chromosome 8 and 21 in myeloid bone marrow cells detected by three dimensional molecular cytogenetics. Int J Mol Med (2009) 0.87
Social support and survival in patients with acute myeloid leukaemia. Support Care Cancer (2006) 0.87
An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia. J Antimicrob Chemother (2005) 0.87
Minimal residual disease based on patient specific Flt3-ITD and -ITT mutations in acute myeloid leukemia. Leuk Res (2005) 0.86
Results of comprehensive geriatric assessment effect survival in patients with malignant lymphoma. J Cancer Res Clin Oncol (2010) 0.86
Enlarged chromosome 13 p-arm hiding a cryptic partial trisomy 6p22.2-pter. Prenat Diagn (2003) 0.85
Evidence for interphase DNA decondensation transverse to the chromosome axis: a multicolor banding analysis. Int J Mol Med (2002) 0.85
Health-related quality of life in elderly cancer patients, elderly non-cancer patients and an elderly general population. Eur J Cancer Care (Engl) (2009) 0.84
Depression and functional impairment independently contribute to decreased quality of life in cancer patients prior to chemotherapy. Acta Oncol (2008) 0.84
Advances in the pharmacological treatment of gastro-oesophageal cancer. Drugs Aging (2009) 0.84
Rearrangement of the ETS genes ETV-1, ETV-4, ETV-5, and ELK-4 is a clonal event during prostate cancer progression. Hum Pathol (2012) 0.83
Specific detection of Flt3 point mutations by highly sensitive real-time polymerase chain reaction in acute myeloid leukemia. J Lab Clin Med (2005) 0.83
Delineation of yet unknown cryptic subtelomere aberrations in 50% of acute myeloid leukemia with normal GTG-banding karyotype. Int J Oncol (2009) 0.83
Differential expression of cancer-related genes by single and permanent exposure to bone morphogenetic protein 2. J Cancer Res Clin Oncol (2008) 0.82
[Health services research and geriatrics: deficits and research approaches using the example of colorectal carcinoma and anaemia]. Z Arztl Fortbild Qualitatssich (2007) 0.82
Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5-azacytidine and literature review. Eur J Haematol (2014) 0.81
Additive effects of PI3-kinase and MAPK activities on NB4 cell granulocyte differentiation: potential role of phosphatidylinositol 3-kinase gamma. J Cancer Res Clin Oncol (2008) 0.81
Karyotyping of human synaptonemal complexes by cenM-FISH. Eur J Hum Genet (2003) 0.81
First postnatal case of mosaic del(22)/r(22). Prenat Diagn (2003) 0.81
Inherited cryptic chromosomal aberrations may be more easily detected in their balanced forms: a case report with hidden der(1)t(1;17)(q44;p13.2). Prenat Diagn (2004) 0.80
Premenopausal breast cancer: chemotherapy and endocrine therapy. Drugs (2002) 0.80
Myelodysplastic syndromes: aspects of current medical care and economic considerations in Germany. Onkologie (2008) 0.80
Somatic copy number alterations by whole-exome sequencing implicates YWHAZ and PTK2 in castration-resistant prostate cancer. J Pathol (2013) 0.79
Detection of cryptic chromosomal aberrations in the in vitro non-proliferating cells of acute myeloid leukemia. Int J Oncol (2005) 0.79
Analyses of minimal residual disease based on Flt3 mutations in allogeneic peripheral blood stem cell transplantation. J Cancer Res Clin Oncol (2005) 0.79
Prevalence of anemia in elderly patients in primary care: impact on 5-year mortality risk and differences between men and women. Curr Med Res Opin (2009) 0.79
Genotype/phenotype analysis in a patient with pure and complete trisomy 12p. Am J Med Genet A (2004) 0.79
Short-term monitoring of cognitive functions before and during the first course of treatment. J Cancer Res Clin Oncol (2006) 0.79
First patient with trisomy 21 accompanied by an additional der(4)(:p11 --> q11:) plus partial uniparental disomy 4p15-16. Am J Med Genet A (2003) 0.78
Necrobiotic xanthogranuloma-rapid progression under treatment with melphalan. Eur J Dermatol (2005) 0.78
Characterization of Small Marker Chromosomes (SMC) by Recently Developed Molecular Cytogenetic Approaches. J Assoc Genet Technol (2003) 0.78
Efficacy and feasibility of cyclophosphamide combined with intermediate- dose or high-dose cytarabine for relapsed and refractory acute myeloid leukemia (AML). J Cancer Res Clin Oncol (2014) 0.78
Three new cases with a supernumerary ring chromosome 1. Clin Dysmorphol (2005) 0.77
Double high-dose chemotherapy with adriamycin, paclitaxel, cyclophosphamide, and thiotepa followed by autologous peripheral blood stem cell transplantation in women with metastatic breast cancer. J Cancer Res Clin Oncol (2003) 0.77
A multiple translocation event in a patient with hexadactyly, facial dysmorphism, mental retardation and behaviour disorder characterised comprehensively by molecular cytogenetics. Case report and review of the literature. Eur J Pediatr (2003) 0.77
Care of breast cancer in the elderly woman--what does comprehensive geriatric assessment (CGA) help? Support Care Cancer (2003) 0.77
Increase of interleukin-18 serum levels after engraftment correlates with acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation. J Cancer Res Clin Oncol (2004) 0.77
[Brain metastases of colorectal carcinomas]. Med Klin (Munich) (2002) 0.77
Medium-term effects of chemotherapy in older cancer patients. Support Care Cancer (2005) 0.76
[The situation of elderly patients]. Onkologie (2008) 0.76
Two more possible pitfalls of rapid prenatal diagnostics using interphase nuclei. Prenat Diagn (2002) 0.76
First case of trisomy 13 plus mosaic trisomy 1q. Fetal Diagn Ther (2002) 0.76
Clonal T-LGL population mimicking leukemia in Felty's syndrome--part of a continuous spectrum of T-LGL proliferations? Ann Hematol (2013) 0.76
Trisomy 8 as the sole chromosomal aberration in myelocytic malignancies: a comprehensive molecular cytogenetic analysis reveals no cryptic aberrations. Cancer Genet Cytogenet (2003) 0.75
Docetaxel for advanced gastric cancer? J Clin Oncol (2007) 0.75
Reply to L.K. Mell et al. J Clin Oncol (2014) 0.75
Unilateral optic neuropathy following subdural hematoma: a case report. J Med Case Rep (2010) 0.75
Automated detection of residual cells after sex-mismatched stem-cell transplantation - evidence for presence of disease-marker negative residual cells. Mol Cytogenet (2009) 0.75
Specific pattern of protein expression in acute myeloid leukemia harboring FLT3-ITD mutations. Leuk Lymphoma (2007) 0.75
A retrospective review of diagnosis and treatment modalities of neuroendocrine tumors (excluding primary lung cancer) in 10 oncological institutions of the East German Study Group of Hematology and Oncology (OSHO), 2010-2012. J Cancer Res Clin Oncol (2015) 0.75